BACKGROUND	We revisited this procedure by optimizing all procedural steps-the use of glycoprotein IIb/IIa blockers , direct stenting , adequate radiation coverage , avoidance of edge damage , source centering , intravascular ultrasound-guided dosimetry , and continuation of a dual anti-platelet regimen for one year .\